Needs, risks, and outcomes of patients admitted to a post liver transplant intensive care unit (POLTICU) differ in important ways from those admitted to pretransplant intensive care units (ICUs). The aim of this study was to create the optimal model to risk stratify POLTICU patients.
Methods:
Consecutive patients who underwent first deceased donor liver transplantation (LT) at a large United States center between 2008 and 2014 were followed from admission to LT and to discharge or death. Receiver–operating characteristic analysis was performed to assess the value of various scores in predicting in-hospital mortality. A predictive model was developed using logistic regression analysis.
Results:
A total of 697 patients underwent LT, and 3.2% died without leaving the hospital. A model for in-hospital mortality was derived from variables available within 24 hours of admission to the POLTICU. Key variables best predicting survival were white blood cell count, 24-hour urine output, and serum glucose. A model using these variables performed with an area under the curve (AUC) of 0.88, compared to the Acute Physiology and Chronic Health Evaluation III and Model for End-Stage Liver Disease, which performed with AUCs of 0.74 and 0.60, respectively.
Conclusion:
An improved model, the early mortality after LT (EMALT) score, performs better than conventional models in predicting in-hospital mortality after LT.
MalinchocMKamathPSGordonFDPeineCJRankJter BorgPC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871.
2.
WiesnerREdwardsEFreemanRet al; United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96.
3.
BigginsSWRodriguezHJBacchettiPBassNMRobertsJPTerraultNA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41(1):32–39.
4.
SanyalAJGenningCReddyKRet al; North American Study for the Treatment of Refractory Ascites Group. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124(3):634–641.
5.
HeumanDMAbou-AssiSGHabibA, et al.Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40(4):802–810.
6.
LucaAAngermayrBBertoliniG, et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl. 2007;13(8):1174–1180.
7.
HuoTIWangYWYangYY, et al.Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int. 2007;27(4):498–506.
8.
BiselliMGittoSGramenziA, et al.Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner?Liver Transpl. 2010;16(8):964–973.
9.
KleinKBStafinskiTDMenonD. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS One. 2013;8(12):e80661.
10.
HayashiPHFormanLSteinbergT, et al.Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003;9(7):737–740.
11.
CholongitasEMarelliLShusangV, et al.A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12(7):1049–1061.
12.
BrownRSKumarKSRussoMW, et al.Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl. 2002;8(3):278–284.
13.
DesaiNMMangeKCCrawfordMD, et al.Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation. 2004;77(1):99–106.
14.
HalldorsonJBBakthavatsalamRFixOReyesJDPerkinsJD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009;9(2):318–326.
15.
FengSGoodrichNPBragg-GreshamJL, et al.Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–790.
16.
CameronAMGhobrialRMYersizH, et al.Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243(6):748–753.
17.
SchremHReichertBFrühaufN, et al.The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity. Ann Transplant. 2012;17(3):5–13.
18.
RanaAHardyMAHalazunKJ, et al.Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8(12):2537–2546.
19.
WeismüllerTJProkeinJBeckerT, et al.Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol. 2008;43(6):736–746.
20.
ReichertBBeckerTWeismüllerTJ, et al.Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30. Ann Transplant. 2012;17(2):11–17.
21.
KnausWAWagnerDPDraperEAet al; The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619–1636.
22.
Le GallJRLemeshowSSaulnierF. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963.
23.
VincentJLde MendonçaACantraineF, et al.Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800.
24.
ChungISParkMKoJSGwakMSKimGSLeeSK. Which score system can best predict recipient outcomes after living donor liver transplantation?Transplant Proc. 2012;44(2):393–395.
25.
ElsayedFGSholkamyAAElshazliMElshafieMNaguibM. Comparison of different scoring systems in predicting short-term mortality after liver transplantation. Transplant Proc. 2015;47(4):1207–1210.
26.
SchremHReichertMReichertB, et al.Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30. Langenbecks Arch Surg. 2012;397(5):717–726.
27.
KimWRLakeJRSmithJM, et al.OPTN/SRTR 2015 Annual data report: liver. Am J Transplant. 2017;17(suppl 1):174–251.
28.
ScarboroughJEPietrobonRMarroquinCE, et al.Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States. J Gastrointest Surg. 2007;11(1):82–88.
29.
WaiHStepanovaMSaabSErarioMSrishordMYounossiZM. Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009. Transplantation. 2014;97(1):98–103.
30.
DeLongERDeLongDMClarke-PearsonDL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.
31.
WagenerGRaffelBYoungATMinhazMEmondJ. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score. Liver Transpl. 2013;19(5):534–542.
32.
BenkoTGallinatAMinorT, et al.The postoperative model for end stage liver disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers. Eur J Gastroenterol Hepatol. 2017;29(6):716–722.
33.
ParejaECortesMHervásD, et al.A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl. 2015;21(1):38–46.
34.
JochmansIFieuwsSMonbaliuDPirenneJ. “Model for early allograft function” outperforms “early allograft dysfunction” as a predictor of transplant survival. Transplantation. 2017;101(8):e258–e264.
35.
KimbellBBoydKKendallMIredaleJMurraySA. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5(11):e009241.
